NERV vs IMMX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

NERV

32.7
AI Score
VS
IMMX Wins

IMMX

45.5
AI Score

Investment Advisor Scores

NERV

33score
Recommendation
SELL

IMMX

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NERV IMMX Winner
Net Income 1.44M -21.64M NERV
Operating Income -21.85M -23.26M NERV
ROE -5.6% -9.5% NERV
ROA 3.9% -9.1% NERV
Total Assets 37.14M 239.11M IMMX
Cash 21.36M 225.49M IMMX
Current Ratio 7.85 25.13 IMMX

Relative Price Performance (Last 90 Days)

NERV 1M: -5.0% · 3M: -48.0% IMMX 1M: -9.7% · 3M: -30.9%

Current Technical Phase

NERV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -23.0%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $2.30

IMMX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.8%), weak momentum, RSI 43

RSI (14): 42.7 · Price: $7.84

Fundamentals Snapshot

Metric NERV IMMX
Market Cap — —
Forward P/E -5.5 -8.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -33.83 -0.88
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IMMX is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.